1-12 of 12
Melanie Oates
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

A Prospective Analysis of Outcomes Following Successive Lines of Treatment in Mantle Cell Lymphoma in an Unselected Previously Untreated Population: The UK MCL Biobank

Sarah Mant, Georgina Naylor, Nicola Crosbie, Sree Aroori, Mark J Bishton, Kristian Bowles, Safia Dawi, Toby A. Eyre, Wendy Ingram, Abigail Martin, Christopher McNamara, Melanie Oates, Andrew Pettitt, Claire Scully, Brian Wainman, Mark Warner, Simon Rule, David John Lewis
Journal: Blood
Blood (2024) 144 (Supplement 1): 1641.
https://doi.org/10.1182/blood-2024-209701
Published: 2024
Journal Articles

Deep Immune Profiling Identifies Novel T-Cell Subpopulations That Influence Specific Clinical Outcomes in Chronic Lymphocytic Leukaemia (CLL)

Yeong Jer Lim, Andrew Duckworth, Kim Clarke, Paul Kennedy, Melanie Oates, Matthew Gornall, Nagesh Kalakonda, Joseph Slupsky, Andrew Pettitt
Journal: Blood
Blood (2023) 142 (Supplement 1): 4626.
https://doi.org/10.1182/blood-2023-185091
Published: 2023
Journal Articles

Immunomodulatory Effects of Chemo-Immunotherapy ± Idelalisib in Chronic Lymphocytic Leukaemia (CLL)

Yeong Jer Lim, Andrew Duckworth, Kim Clarke, Melanie Oates, Matthew Gornall, Nagesh Kalakonda, Joseph Slupsky, Andrew Pettitt
Journal: Blood
Blood (2023) 142 (Supplement 1): 1455.
https://doi.org/10.1182/blood-2023-185063
Published: 2023
Journal Articles

High Dimensional Detection of Non-Malignant B-Cells and Its Clinical Implications in Patients with Chronic Lymphocytic Leukaemia (CLL) Undergoing Frontline Therapy

Yeong Jer Lim, Andrew Duckworth, Kim Clarke, Melanie Oates, Matthew Gornall, Nagesh Kalakonda, Joseph Slupsky, Andrew Pettitt
Journal: Blood
Blood (2023) 142 (Supplement 1): 1894.
https://doi.org/10.1182/blood-2023-185018
Published: 2023
Journal Articles

Highly Comprehensive Genomic Testing for CLL: WGS, One Key to CLL Patient Stratification

Kate E Ridout, PhD, Pauline Robbe, MSc, PhD, Doriane Cavalieri, MSc, Jennifer Becq, PhD, Miao He, PhD, Ruth Clifford, FRCPath, PhD, Niamh Appleby, FRCPath, MD, Reem Alsolami, PhD, Adam Burns, BSc, PhD, Melanie Oates, PhD, Basile Stamatopoulos, PhD, Samantha Knight, PhD, Alona Sosinsky, PhD, Pavlos Antoniou, PhD, Mark Ross, PhD, David Bentley, PhD, Andrew Pettitt, FRCPath, PhD, Peter Hillmen, MB ChB, PhD FRCP, FRCPath, Mark Caulfield, PhD, Anna Schuh, MD PhD
Journal: Blood
Blood (2018) 132 (Supplement 1): 3115.
https://doi.org/10.1182/blood-2018-99-115935
Published: 2018
Journal Articles

Identifying High-Risk CLL to Predict Early Relapse after FCR Based Treatment Using Whole Genome Sequencing: First Results from the Genomics England CLL Pilot

Pauline Robbe, Kate Ridout, Jennifer Becq, Miao He, Ruth Clifford, MD, Reem Alsolami, Adam Burns, Samantha JL Knight, Melanie Oates, Dena Howard, Andrew R. Pettitt, Augusto Rendon, Niko Popitsch, Peter Hillmen, Jenny C Taylor, Mark Caulfield, David Bentley, Clare Turnbull, Anna Schuh, MD PhD
Journal: Blood
Blood (2016) 128 (22): 2022.
https://doi.org/10.1182/blood.V128.22.2022.2022
Published: 2016
Journal Articles

Genomic Dissection of the Fcγ Receptor Region in the Context of Monoclonal Antibody Therapy

Chantal Hargreaves, PhD, Chisako Iriyama, MD PhD, Matthew JJ Rose-Zerilli, PhD, Charlotte Lee, BSc, Kathleen Potter, PhD, Rosalind Ganderton, Khiyam Hussain, Lee Machado, PhD, Edward Hollox, Sarah E Coupland, MBBS, PhD, Michael Stackpole, Melanie Oates, PhD, Andrew R. Pettitt, PhD MRCPath, Mark Cragg, PhD, Jonathan C Strefford, PhD
Journal: Blood
Blood (2014) 124 (21): 2996.
https://doi.org/10.1182/blood.V124.21.2996.2996
Published: 2014
Journal Articles

The Identification of Further Minimal Regions of Overlap in Chronic Lymphocytic Leukemia Using High-Resolution SNP Arrays

Samantha JL Knight, PhD CBiol, MSB, FRCPath, Ruth Clifford, MD, Pauline Robbe, MSc, Sara DC Ramos, MSc, Adam Burns, BSc, Adele T Timbs, MSc, Reem Alsolami, BSc, Susanne Weller, PhD, Angela Hamblin, MDPhD, Joanne Mason, PhD, Melanie Oates, PhD, Michalis Titsias, PhD, Christopher Yau, DPhil, Chris C Holmes, PhD, Andrew R Pettitt, FRCP, PhD, Peter Hillmen, MB, ChB, PhD, Jenny Taylor, DPhil, Anna Shuh, MD PhD FRCP, FRCPath
Journal: Blood
Blood (2014) 124 (21): 3315.
https://doi.org/10.1182/blood.V124.21.3315.3315
Published: 2014
Journal Articles

Development of a High-Throughput Screening Assay with Nurse-like Cell-Based Microenviroment in Chronic Lymphoid Leukemia Cells.

Daniel Primo, PhD, Javier De la Serna, MD PhD, Joaquin Martinez, MD, Marcos González, MD, Javier Lopez, Abelardo Bárez, Macarena Ortiz, MD, Javier Loscertales, MD, Julian Vidán, MD, Alicia Rodriguez, MD, Marta Polo, MD, Sandra Irhaeta, MD, Jose Maria Alonso, MD, Jose Antonio Queizan, MD, Jose Angel Hernandez Rivas, MD, María Jesus Peñarrubia, MD, Julian Gorrochategui, Ana Belen Espinosa, PhD, Elena Arroyo, Melanie Oates, PhD, Andrew R Pettit, FRCP, PhD, Joan Ballesteros, PhD, Pilar Hernandez, PhD
Journal: Blood
Blood (2014) 124 (21): 3639.
https://doi.org/10.1182/blood.V124.21.3639.3639
Published: 2014
Journal Articles

Total Proteome Analysis Identifies Migration Defects As a Major Pathogenetic Factor in IGHV-Unmutated Chronic Lymphocytic Leukemia

Gina L Eagle, PhD, Rosalind E Jenkins, PhD, Kathleen J Till, PhD, Jithesh Puthen, PhD, Ke Lin, PhD, Gillian G Johnson, PhD, Melanie Oates, PhD, Kevin Park, PhD, Neil R Kitteringham, PhD, Jianguo Zhuang, PhD, Andrew R Pettitt, MRCP, PhD
Journal: Blood
Blood (2014) 124 (21): 718.
https://doi.org/10.1182/blood.V124.21.718.718
Published: 2014
Journal Articles

Towards Response Prediction Using Integrated Genomics in Chronic Lymphocytic Leukaemia: Results on 250 First-Line FCR Treated Patients from UK Clinical Trials

Ruth M Clifford, MD, Pauline Robbe, MSc, Susanne Weller, PhD, Adele T Timbs, MSc, Michalis Titsias, PhD, Adam Burns, BSc, Maite Cabes, BSc, Reem Alsolami, MSc, Christopher Yau, DPhil, Angela Hamblin, MDPhD, Joanne Mason, PhD, Melanie Oates, PhD, Andrew Pettitt, MD PhD, Chris Holmes, PhD, Peter Hillmen, MB, ChB, PhD, Jenny Taylor, DPhil, Samantha JL Knight, PhD CBiol, MSB, FRCPath, Anna Schuh, MDPhD
Journal: Blood
Blood (2014) 124 (21): 1942.
https://doi.org/10.1182/blood.V124.21.1942.1942
Published: 2014
Journal Articles

CYP2B6*6 is an independent determinant of inferior response to fludarabine plus cyclophosphamide in chronic lymphocytic leukemia

Gillian G. Johnson, Ke Lin, Trevor F. Cox, Melanie Oates, David R. Sibson, Richard Eccles, Bryony Lloyd, Laura-Jayne Gardiner, Daniel F. Carr, Munir Pirmohamed, Jonathan C. Strefford, David G. Oscier, David Gonzalez de Castro, Monica Else, Daniel Catovsky, Andrew R. Pettitt
Journal: Blood
Blood (2013) 122 (26): 4253–4258.
https://doi.org/10.1182/blood-2013-07-516666
Published: 2013
Includes: Supplemental data